WHY CLEANROOM PPE BELONGS IN YOUR CCS

Contamination Control Starts With Every Part: Why Cleanroom PPE Belongs in Your Contamination Control Strategy

Cleanroom PPE is often specified, validated and purchased one product category at a time. Contamination risk doesn't work that way.

Garments, gloves, eye and face protection, footwear, and RABS & isolator glove systems are often selected as separate product categories, sometimes from different suppliers and for different reasons. That's manageable from a purchasing perspective. Inside a pharmaceutical or biopharmaceutical cleanroom, however, those products are worn together by the same operator, performing the same task, within the same contamination-control programme.

Ansell's Head-to-Toe approach starts from a different premise: PPE should be treated as a coordinated people-control within the Contamination Control Strategy (CCS), selected according to application, exposure risk, cleanroom classification and task criticality, rather than as unrelated product categories.

EU GMP Annex 1 supports this view. The European Commission's 2022 revision states that a CCS should define critical control points, assess the effectiveness of controls used to manage contamination risk, and consider personnel as one of the key elements of the strategy.

For QA, Microbiology and cleanroom teams, the practical question is simple:

Can you explain why every part of your cleanroom PPE is used, how it works with the rest of the system, and what role it plays within your CCS?

Why Individual PPE Decisions Need a Connected Rationale

Each of gloves, garments, goggles, facemasks, overboots and RABS & isolator glove systems is a valid decision on its own. The challenge appears when those decisions are not connected through a common risk-based rationale.

Operators move, reach, inspect, intervene, transfer, disinfect and handle materials throughout a shift. Every action creates an opportunity for contamination to be introduced, transferred or controlled.

PPE sits directly at that interface. Garments help contain particles shed by the body. Gloves create a barrier at critical surfaces. Eye and face protection help reduce exposure and contamination transfer. RABS & isolator glove systems become the operator's direct interface with first-air.

Annex 1 identifies personnel as one of the key elements of the CCS and can be a significant source of potential contamination. within a cleanroom environment. PPE therefore becomes more than an entry requirement; it becomes an active people-control designed to help reduce contamination risk during routine and critical interventions.

At the same time, even the most advanced PPE cannot compensate for poor gowning practices, inadequate training or inconsistent operator behavior. PPE selection, operator competency and gowning procedures should therefore be considered together as part of the contamination-control strategy.

Real-World Example: When PPE Selection Isn't Connected to Risk

One pharmaceutical manufacturer operating a new RABS environment discovered that its existing glove system lacked FDA approval, Annex 1 documentation and the cleanroom compatibility required for sterile manufacturing. After moving to ISO Class 4-compatible BioClean™ GGL36NIT59 gloves and supporting validation documentation, contamination risks were reduced and validation time was cut by up to 50%.